Evidence map›Paper›PMID 36633791›Full record

ReviewJournal of endocrinological investigation2023

Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes.

R Mazzilli, C Rucci, A Vaiarelli, D Cimadomo, F M Ubaldi, C Foresta, A Ferlin

Open access · hybridAbstract readReview
In one paragraph

Review in Journal of endocrinological investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 2 pooled it
16.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Optimizing post-wash TPMSC for intrauterine insemination: A key strategy to improve pregnancy outcomes.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

R MazzilliAndrology Unit, Department of Clinical and Molecular Medicine, Sant'Andrea Hospital, Sapienza University of Rome, Via Di Grottarossa, 1036-1039, 00100, Rome, Italy. Rossella.mazzilli@uniroma1.it.ORCID http://orcid.org/0000-0001-6707-3413
C RucciGeneraLife IVF, Clinica Valle Giulia, Rome, Italy.
A VaiarelliGeneraLife IVF, Clinica Valle Giulia, Rome, Italy.
D CimadomoGeneraLife IVF, Clinica Valle Giulia, Rome, Italy.
F M UbaldiGeneraLife IVF, Clinica Valle Giulia, Rome, Italy.
C ForestaDepartment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy.
A FerlinDepartment of Medicine, Unit of Andrology and Reproductive Medicine, University of Padova, Padova, Italy.
Clinica Valle Giulia · ITUniversity of Padua · ITCTO Andrea Alesini · ITUniversity of Rome Tor Vergata · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInfertility, which is defined as the inability to conceive after at least 12 months of regular unprotected sexual intercourses, affects about 15-20% of couples worldwide and a male factor is involved in about half of the cases. The development of assisted reproductive technology (ART) made it possible to conceive also to individuals affected from severe oligospermia or azoospermia. However, the impact of the male factor on embryo development, implantation, prevalence of chromosomal abnormalities, genetic and epigenetic alterations, and clinical and obstetric outcomes is still controversial. PURPOSE: This narrative review examines the indications, minimum access criteria, and outcomes by individual ART technique in relation to the male factor.

Indexed as

AzoospermiaInfertilityInfertility, MaleChromosome AberrationsFemaleHumansMalePregnancyReproductive Techniques, AssistedAssisted reproductive technology (ART)AzoospermiaICSI–IVFOligozoospermiaSevere male factor

Identifiers

PMID36633791
PMCPMC10185595
OpenAlexW4315752726

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.